Space stocks are diverging sharply at midday Wednesday, with the market’s newest space giant sliding even as smaller rivals rally on their own catalysts. SpaceX (NASDAQ:SPCX) shares are down 6% to $159.81, while Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) stock is up 4% to $105.64 and Virgin Galactic (NYSE:SPCE) stock is climbing 3% to $2.99.
The split looks technical rather than fundamental. SpaceX’s slide comes despite a fresh bullish initiation from Wedbush’s Dan Ives, and it lines up with a broader NASDAQ pullback. The Invesco QQQ Trust (NASDAQ:QQQ) is off 1% intraday.
Rotation out of the newly listed SpaceX into other space names appears to be part of the story. The Polymarket contract for SPCX finishing lower on July 1 is trading at a 93% implied probability.
SpaceX Falls Despite a Bullish Ives Initiation
Ives launched coverage of SpaceX stock at Outperform with a $190 price target, implying 12% upside from Tuesday’s $171 close. His thesis frames SpaceX as a three-way bet on launch, connectivity, and AI compute.
Starlink is positioned as the profit engine, with around 12 million subscribers and ARPU near $66. Launch operates as an internal cost center that ran about 170 missions in 2025, and the Colossus compute cluster carries roughly $28 billion in annualized deals with customers including Anthropic and Alphabet‘s (NASDAQ:GOOGL) Google.
The bear case is real for SpaceX. Starship remains unproven after 12 test flights with no in-orbit propellant transfer yet, and Ives concedes the heavy losses represent what he calls “an investment cycle, not a business losing ground.” The stock is still up 6% since its June 12 debut.
Rocket Lab Rides Iridium Deal Momentum
Rocket Lab’s move is powered by CEO Peter Beck’s $8 billion acquisition of Iridium Communications, announced this week. The combination targets direct-to-device satellite service using Iridium’s low-Earth-orbit constellation and spectrum, an area where SpaceX and Amazon (NASDAQ:AMZN) are pushing hard.
The fundamentals back up the enthusiasm. Rocket Labs’ Q1 FY2026 revenue came in at $200.35 million, up 64% year-over-year, with backlog of $2.2 billion. Rocket Lab shares are up 50% year to date (YTD) even after a rough June.
Reddit sentiment on the deal has been strongly positive, with the main acquisition thread on r/stocks reaching 370 upvotes and prediction markets assigning 82% odds of RKLB reaching $112 in July.
Virgin Galactic Bounces From Oversold Levels
Virgin Galactic’s move looks like a technical bounce rather than a catalyst-driven rally. Shares are down 61% over the past month, and Reddit sentiment collapsed to very bearish readings through mid-June before today’s rebound.
The operational story is intact but modest. Virgin Galactic’s management guided to flight testing on track for Q3 2026 with first commercial spaceflight planned for Q4 2026. Moreover, the company’s market cap sits at just $333 million, making moves at this level easy to trigger.
Leveraged ETFs and What to Watch
Traders looking for amplified exposure are active in the Defiance Daily Target 2X Long SpaceX ETF (NYSEARCA:SPCU), down 13%, and the Defiance Daily Target 2X Short SpaceX ETF (CBOE:SPCQ), up 12%. Both carry 1% expense ratios and decay over multi-day holds.
The next set piece for SpaceX arrives quickly. The stock joins the NASDAQ 100 before the open on July 7, an event JPMorgan estimates could draw about $4.3 billion in index-fund buying. That mechanical bid could reset sentiment after this week’s post-IPO digestion.
Investors can watch for whether the SpaceX slide holds into the close and whether Rocket Lab’s Iridium enthusiasm persists once regulatory approval questions surface. One session of divergence doesn’t change the long-term thesis on any of these names, and position sizing should reflect how speculative the group remains.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks